Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide binding

FEMS Microbiology Letters

Volumn 183, Issue 2, 2000, Pages 209-214

  Goldman, Robert C ^a   Baizman, Eugene R ^a   Longley, Clifford B ^a   Branstrom, Arthur A ^a  

^a Department of Biological Research   (United States)

Author keywords

Chlorobiphenyl desleucyl vancomycin; Glycopeptide; Glycopeptide resistance; Peptidoglycan synthesis

Indexed keywords

GLYCOSYLTRANSFERASE; MURAMYL PEPTIDE; MURAMYL TRIPEPTIDE; PEPTIDOGLYCAN; VANCOMYCIN; VANCOMYCIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DIMERIZATION; DRUG POTENCY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; GLYCOSYLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIA; DIPEPTIDES; GLYCOSYLATION; PEPTIDOGLYCAN; VANCOMYCIN;

EID: 0033965502     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(99)00639-4     Document Type: Article

References (16)

1. Malabarba A., Nicas T.I., Thompson R.C. Structural modifications of glycopeptide antibiotics. Med. Res. Rev. 17:1997;69-137.
2. Nagarajan R. Structure-activity relationships of vancomycin-type glycopeptide antibiotics. J. Antibiot. (Tokyo). 46:1993;1181-1195.
3. Walsh C.T., Fisher S.L., Park I.S., Prahalad M., Wu Z. Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem. Biol. 3:1996;21-28.
4. Walsh C.T. Vancomycin resistance: decoding the molecular logic. Science. 261:1993;308-309.
5. Leclercq R., Courvalin P. Resistance to glycopeptides in enterococci. Clin. Infect. Dis. 24:1997;545-554.
6. Leclercq R. Glycopeptides: mechanism of action and of resistance. Presse Med. 28:1999;720-721.
7. Arthur M., Reynolds P.E., Dépardieu F., Evers S., Dutka-Malen S., Quintiliani R. Jr., Courvalin P. Mechanisms of glycopeptide resistance in enterococci. J. Infect. 32:1996;11-16.
8. Ge M., Chen Z., Onishi H.R., Kohler J., Silver L.L., Kerns R., Fukuzawa S., Thompson C., Kahne D. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-ala-D-ala. Science. 284:1999;507-511.
9. Williams D.H. The glycopeptide story-how to kill the deadly 'superbugs'. Nat. Prod. Rep. 13:1996;469-477.
10. Allen N.E., LeTourneau D.L., Hobbs J.N. Jr. Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues. Antimicrob. Agents Chemother. 41:1997;66-71.
11. Ikeda M., Wachi M., Matsuhashi M. The murG gene of the Escherichia coli chromosome encoding UDP-N-acetylglucosamine:undecaprenyl-pyrophosphoryl-N-acetylmuramoyl- pentapeptide N-acetylglucosaminyl transferase. J. Gen. Appl. Microbiol. 38:1992;53-62.
12. Billot-Klein D., Shlaes D., Bryant D., Bell D., Legrand R., Gutmann L., van Heijenoort J. Presence of UDP-N-acetylmuramyl-hexapeptides and -heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin, or vancomycin. J. Bacteriol. 179:1997;4684-4688.
13. Kohlrausch U., Holtje J.V. One-step purification procedure for UDP-N-acetylmuramyl-peptide murein precursors from Bacillus cereus. FEMS Microbiol. Lett. 62:1991;253-257.
14. Nicas T.I., Wu C.Y., Hobbs J.N. Jr., Preston D.A., Allen N.E. Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob. Agents Chemother. 33:1989;1121-1124.
15. Anderson J.S., Meadow P.M., Haskin M.A., Strominger J.L. Biosynthesis of the peptidoglycan of bacterial cell walls. I. Utilization of uridine diphosphate acetylmuramyl pentapeptide and uridine diphosphate acetylglucosamine for peptidoglycan synthesis by particulate enzymes from Staphylococcus aureus and Micrococcus lysodeikticus. Arch. Biochem. Biophys. 116:1966;487-515.
16. van Heijenoort Y., Gomez M., Derrien M., Ayala J., van Heijenoort J. Membrane intermediates in the peptidoglycan metabolism of Escherichia coli: possible roles of PBP 1b and PBP 3. J. Bacteriol. 174:1992;3549-3557.